statistiche ricercatore

Nome	#
Acute complications following endoscopic intragastric balloon insertion for treatment of morbid obesity in elderly patients. A single center experience	92
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer.	56
No Difference in Ghrelin-Producing Cell Expression in Obese Versus Non-obese Stomach: a Prospective Histopathological Case-Control Study	51
Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.	35
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.	33
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.	30
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).	30
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.	29
null	27
Jejuno-ileal bypass in the treatment of severe obesity: transverse or vertical approach?	22
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up.	19
Totale	424

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	2	0	0	0	0	0	0	0	0	0	0	0	2
2019/2020	43	13	1	3	0	2	0	0	0	0	9	8	7
2020/2021	65	1	4	6	6	7	10	7	2	6	5	5	6
2021/2022	92	1	1	2	2	2	7	2	3	8	7	33	24
2022/2023	137	13	15	7	7	15	14	0	13	25	22	5	1
2023/2024	50	4	8	17	3	3	10	0	5	0	0	0	0
Totale													424